Table 5.
Adverse effects according to treatment type.
| Adverse effect | Monotherapy, n (%) n = 365 | Concomitant treatment, n (%) n = 285 | Total, n (%) N = 650 | p* |
|---|---|---|---|---|
| Any adverse effect | 43 (11.8) | 96 (33.7) | 139 (21.4) | <0.001 |
| Sedation | 14 (3.8) | 62 (21.8) | 76 (11.7) | <0.001 |
| Weight gain | 9 (2.5) | 54 (18.9) | 63 (9.7) | <0.001 |
| Loss of appetite | 9 (2.5) | 3 (1.1) | 12 (1.8) | 0.184 |
| Bruxism | 8 (2.2) | 1 (0.4) | 9 (1.4) | 0.085 |
| Palpitations | 5 (1.4) | 2 (0.7) | 7 (1.1) | 0.475 |
| Nausea | 2 (0.5) | 2 (0.7) | 4 (0.6) | 1.000 |
| Sexual dysfunction | 0 (0.0) | 3 (1.1) | 3 (0.5) | 0.084 |
| Akathisia | 1 (0.3) | 1 (0.4) | 2 (0.3) | 1.000 |
| Hyperprolactinaemia | 0 (0.0) | 2 (0.7) | 2 (0.3) | 0.192 |
| Headache | 1 (0.3) | 0 (0.0) | 1 (0.2) | 1.000 |
| QTc prolongation | 0 (0.0) | 1 (0.4) | 1 (0.2) | 0.438 |
| Vomiting | 1 (0.3) | 0 (0.0) | 1 (0.2) | 1.000 |
| Dry mouth | 1 (0.3) | 0 (0.0) | 1 (0.2) | 1.000 |
| Other | 0 (0.0) | 3 (1.1) | 3 (0.5) | 0.084 |
Adverse effects were counted among the 139 patients with a recorded adverse effect; a patient could have more than one adverse effect. Percentages use the group size shown in the column heading as denominator. *Pearson chi-square test, or Fisher’s exact test when an expected cell count was < 5.